GERALD WIGGS: Open Payments
NPI 1881169662 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 87 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,620
Food & beverage: $1,620
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $304 |
| AstraZeneca Pharmaceuticals LP | 8 | $266 |
| ABBVIE INC. | 14 | $217 |
| Novo Nordisk Inc | 7 | $125 |
| TOLMAR, INC. | 4 | $87 |
| PFIZER INC. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| GlaxoSmithKline, LLC. | 4 | $63 |
| Exact Sciences Corporation | 3 | $48 |
Products named: FARXIGA, OTEZLA, EVENITY, VRAYLAR, REXULTI, JATENZO, XIFAXAN, Wegovy.
Industry payments across NC — which companies pay providers there.
